|
Age in years, Median (Q1-Q3)
|
65 (41–76)
|
63 (40–76)
|
3 (1–7)
|
|
Males, n (%)
|
28 (41.2)
|
49 (55.7)
|
29 (59.2)
|
|
Received antibiotics in last 3 months, n (%)
|
19 (27.9)
|
10 (11.4)
|
9 (18.4)
|
|
Symptom duration, in days, Median (Q1-Q3)
|
7 (4–15)
|
6 (3–10)
|
4 (2–8)
|
|
Presence of comorbidities, n (%)
|
37 (54.4)
|
50 (56.8)
|
2 (4.1)
|
|
Chronic obstructive pulmonary disease
|
24 (35.3)
|
37 (42)
|
0
|
|
History of convulsions in the last month
|
0
|
3 (3.4)
|
2 (4.1)
|
|
Severe pneumoniaa, n (%)
|
15 (22.1)
|
26 (29.5)
|
1 (2.0)
|
|
Frequency of atypical bacteria, n (%)
|
|
M. pneumoniae
|
5 (10.9)
|
4 (5.2)
|
21 (43.8)
|
|
C. pneumoniae
|
3 (6.5)
|
9 (11.7)
|
6 (12.5)
|
|
L. pneumophila
|
3 (6.5)
|
2 (2.6)
|
5 (10.4)
|
|
Length of hospital stay, in days, Median (Q1-Q3)
|
6 (3–9)
|
7 (4–10)
|
4 (2–9)
|
|
In-hospital death, n (%)
|
0
|
8 (9.1)
|
0
|
